Sera Prognostics (SERA) Shares Outstanding (Diluted) (2020 - 2026)
Sera Prognostics (SERA) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 386.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 1.29 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 577.60 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 390.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 454.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 968.57 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 97.90 Mn |
| 10 | Sera Prognostics | 108.53 Mn | 108.53 Mn | -20,000.00 | 50.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 50.26 Mn |
| Mar 31, 2026 | 50.26 Mn |
| Dec 31, 2025 | 47.66 Mn |
| Sep 30, 2025 | 49.53 Mn |
| Jun 30, 2025 | 49.07 Mn |
| Mar 31, 2025 | 41.97 Mn |
| Dec 31, 2024 | 33.16 Mn |
| Sep 30, 2024 | 33.52 Mn |
| Jun 30, 2024 | 32.93 Mn |
| Mar 31, 2024 | 32.22 Mn |
| Dec 31, 2023 | 31.20 Mn |
| Sep 30, 2023 | 31.29 Mn |
| Jun 30, 2023 | 31.08 Mn |
| Mar 31, 2023 | 31.02 Mn |
| Dec 31, 2022 | 30.94 Mn |
| Sep 30, 2022 | 31.01 Mn |
| Jun 30, 2022 | 30.95 Mn |
| Mar 31, 2022 | 30.80 Mn |
| Dec 31, 2021 | 15.00 Mn |
| Sep 30, 2021 | 25.09 Mn |